Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Oligonucleotide therapeutics for hematologic disorders.

N Agarwal1, A M Gewirtz

  • 1Department of Internal Medicine, University of Pennsylvania School of Medicine, Philadelphia, USA.

Biochimica Et Biophysica Acta
|May 12, 2000
PubMed
Summary

Gene therapy using oligonucleotides (ODN) shows promise for treating hematologic diseases, especially myelogenous leukemias. This review discusses the application and challenges of ODN in clinical settings.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Outcomes of immune-checkpoint inhibitor rechallenge in metastatic clear-cell renal cell carcinoma: results from a global real-world evidence study.

ESMO open·2026
Same author

Drone-based sputum transport for TB diagnosis in remote communities.

IJTLD open·2026
Same author

Fetoscopic laser ablation vs standard management for Type-II and Type-III vasa previa.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2026
Same author

Outcomes of immune checkpoint inhibitor rechallenge in advanced urothelial carcinoma: results from a global real-world evidence study.

ESMO open·2025
Same author

Venous thromboembolic event risk with PARP inhibitors in solid tumors: a systematic review and meta-analysis.

ESMO open·2025
Same author

Morphometric analysis of spina bifida after fetal repair shows new subtypes with associated outcomes.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2025

Area of Science:

  • Molecular Biology
  • Genetics
  • Oncology

Background:

  • Significant advancements in understanding genes controlling cell growth and cancer.
  • Growing efforts to translate genetic discoveries into novel therapeutic strategies.
  • Gene-based therapies are emerging as a key focus in treating various diseases.

Purpose of the Study:

  • To review the application of gene-based therapeutic strategies in hematologic diseases.
  • To specifically examine the use of oligonucleotides (ODN) in treating myelogenous leukemias.
  • To discuss challenges and potential solutions related to ODN therapy.

Main Methods:

  • Review of current literature on gene therapy and oligonucleotide applications.
  • Focus on strategies involving gene insertion and gene expression downregulation.

Related Experiment Videos

  • Analysis of clinical trial data for ODN in hematologic disorders.

    • Main Results:

    • Oligonucleotides, including 'antisense' ODN, are a key strategy for downregulating gene expression.
    • These ODN-based therapies have progressed to clinical trials for various conditions.
    • The review highlights the specific relevance to myelogenous leukemias.

    Conclusions:

    • Oligonucleotide-based therapies represent a significant development in treating hematologic malignancies.
    • Further research is needed to overcome challenges associated with ODN delivery and efficacy.
    • ODN hold potential for future therapeutic applications in oncology.